CSMS #49912026

Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date

· View this week in context on the trade timeline

Action requiredPGA UpdateMedium urgency
Share this messageLinkedInEmail
CSMS #49912026 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date U.S. Customs and Border Protection sent this bulletin at 10/28/2021 09:34 AM EDT CSMS #49912026 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date Due to duplication, the Food and Drug Administration (FDA) will be end-dating the Center for Drug Evaluation and Research (CDER) Product Code listed below. The product code below will be end-dated in 30 days. The end-date will be effective on November 28, 2021. End-Dated Code/Description 64O[][]06/Pembrolizumab, Monoclonal Antibodies Instead, please use the product code below. Product Code/Description 62Z[][]31/Pembrolizumab (Anti-Neoplastic - Part II) Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov For assistance with product code identification, the public may also refer to the FDA Product Code Builder .
Agencies affected
FDA

This week in context

This message came out the week of Oct. 23 to Oct. 29, 2021. See that week against the 90 days before it, with every CSMS message by subject and the trade actions behind them.

Trade timeline preview: the week of Oct. 23 to Oct. 29, 2021 highlighted against the 90 days beforeView this week in context on the trade timeline →